<DOC>
	<DOCNO>NCT00274859</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , gemcitabine oxaliplatin , work different way stop growth cancer cell , either kill cell stop divide . Giving one drug ( combination chemotherapy ) may kill cancer cell . PURPOSE : This phase II trial study well give gemcitabine together oxaliplatin work treat patient metastatic cancer receive anthracycline taxane therapy .</brief_summary>
	<brief_title>Gemcitabine Oxaliplatin Treating Patients With Metastatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine objective response rate patient metastatic cancer amenable anthracycline taxane therapy treat gemcitabine hydrochloride oxaliplatin . Secondary - Determine clinical benefit tolerability regimen patient . - Determine progression-free overall survival patient treat regimen . OUTLINE : This open-label , multicenter study . Patients receive gemcitabine hydrochloride IV 100 minute day 1 oxaliplatin IV 2 hour day 2 . Treatment repeat every 2 week absence disease progression unacceptable toxicity . After completion study treatment , patient follow periodically . PROJECTED ACCRUAL : A total 45 patient accrue study .</detailed_description>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm cancer Metastatic disease Measurable metastatic disease ≥ 1 cm spiral CT scan and/or cutaneous lesion ≥ 2 cm Not candidate anthracycline taxane chemotherapy No brain metastasis PATIENT CHARACTERISTICS : ECOG performance status ( PS ) 02 OR Karnofsky PS 60100 % Life expectancy &gt; 12 week Neutrophil count &gt; 1,000/mm^3 Platelet count &gt; 100,000/mm^3 Alkaline phosphatase &lt; 5 time upper limit normal ( ULN ) Bilirubin &lt; 1.5 time ULN Creatinine &lt; 1.5 time ULN OR creatinine clearance &gt; 30 mL/min SGOT SGPT &lt; 3 time ULN ( 5 time ULN liver metastasis present ) No preexist neuropathy Not pregnant nursing No uncontrolled hypercalcemia No familial , social , geographical , psychological condition would preclude study treatment No malignancy consider cured PRIOR CONCURRENT THERAPY : No prior chemotherapy metastatic disease , include anthracyclines taxanes Prior hormonal therapy allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>